Area of research
Internal Medicine · Hematology
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, and Heparin-Induced Thrombocytopenia and Thrombosis.
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data
ESHRE guideline: recurrent pregnancy loss: an update in 2022
ISTH guidelines for antithrombotic treatment in COVID‐19
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
Management of Cerebral Venous Thrombosis Due to Adenoviral <scp>COVID</scp>‐19 Vaccination
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism
How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008–2019: Retrospective analysis of epidemiological data
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database
Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration
Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database